Short- to mid-term results of minimally invasive lateral unicompartmental knee replacement: 133 cases in a non-designer series
- PMID: 36917240
- PMCID: PMC10450018
- DOI: 10.1007/s00402-023-04841-x
Short- to mid-term results of minimally invasive lateral unicompartmental knee replacement: 133 cases in a non-designer series
Abstract
Introduction: The aim of the current study was to demonstrate short- to mid-term survivorship as well as clinical outcome of lateral unicompartmental knee replacement (UKR) with a fixed-bearing (FB) design from a non-designer center using the Oxford Fixed Lateral prosthesis.
Materials and methods: This single-center retrospective cohort study reports the results of 133 consecutive lateral FB-UKR. Survivorship analysis was performed with different endpoints and clinical outcome was measured using the Oxford-Knee-Score (OKS), American-Knee-Society-Score (AKSS-O), range-of-motion (ROM) and visual-analog-scale for pain (VAS).
Results: There were two revision surgeries with conversion to total knee replacements (TKR) due to persistent pain resulting in a survival rate of 98.5% (95% CI 93.5-99.6) with a mean follow-up (FU) of 3.3 ± 1.8 years (range 1-8.5). All outcome scores, VAS and ROM showed a significant improvement at final FU (p < 0.001). The OKS improved from 26 ± 7.8 (range 11-45) preoperatively to 39 ± 8.3 (range 13-48), the AKSS-O from 49.2 ± 14.6 (range 18-90) to 81.8 ± 15.1 (range 40-100), the AKSS-F from 53 ± 23.7 (range 0-100) to 80.4 ± 21.4 (range 5-100) and the ROM from 118 ± 17 (range 90-160) to 134 ± 9.5 (range 100-155).
Conclusions: The short- to mid-term results following lateral FB-UKR demonstrate a high survivorship and good clinical outcome from an independent series. We, therefore, suggest that FB-UKR is a safe treatment option for isolated lateral OA if sufficient surgical experience is provided.
Level of evidence: Retrospective cohort study, level IV.
Keywords: Fixed bearing; Lateral unicompartmental knee replacement; Partial knee arthroplasty; UKA; UKR.
© 2023. The Author(s).
Conflict of interest statement
The Author TR has received research support and personal fees from Arbeitsgemeinschaft Endoprothetik (AE), DGOU, DGOOC, BVOU, DePuy International, Otoo Bock Foundation, Deutsche Arthrose Hilfe, Aesculap, Zimmer, Stiftung Oskar Helene Heim Berlin, Vielberth Foundation Regensburg, the German Ministry of Education and Research as well as the German Federal Ministry of Economic Cooperation and Development not directly related to this study. The Author BP has received institutional grants from Zimmer Biomet not directly related to this study. The Author CM has received institutional financial support from Zimmer Biomet, Medacta, Depuy and Johnson & Johnson not directly related to this study. Furthermore, he has received author payments from Thieme. The other authors declare that they have no competing interests.
Figures


